{"id":"https://openalex.org/W2081086524","doi":"https://doi.org/10.1002/bdd.2510010304","title":"Analysis of allopurinol and oxypurinol in plasma and its application to metabolic studies","display_name":"Analysis of allopurinol and oxypurinol in plasma and its application to metabolic studies","publication_year":1980,"publication_date":"1980-01-01","ids":{"openalex":"https://openalex.org/W2081086524","doi":"https://doi.org/10.1002/bdd.2510010304","mag":"2081086524","pmid":"https://pubmed.ncbi.nlm.nih.gov/7448337"},"language":"en","primary_location":{"id":"doi:10.1002/bdd.2510010304","doi":"https://doi.org/10.1002/bdd.2510010304","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.2510010304","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001007354","display_name":"Stephen Sved","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288894424","display_name":"Health Canada","ror":"https://ror.org/05p8nb362","country_code":"CA","type":"government","lineage":["https://openalex.org/I1288894424"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Sved","raw_affiliation_strings":["Drug Research Laboratories, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Research Laboratories, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada","institution_ids":["https://openalex.org/I1288894424"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059314323","display_name":"David L. Wilson","orcid":"https://orcid.org/0000-0001-9763-1463","observed_orcids":["https://orcid.org/0000-0001-9763-1463"]},"institutions":[{"id":"https://openalex.org/I1288894424","display_name":"Health Canada","ror":"https://ror.org/05p8nb362","country_code":"CA","type":"government","lineage":["https://openalex.org/I1288894424"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. L. Wilson","raw_affiliation_strings":["Drug Research Laboratories, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Research Laboratories, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada","institution_ids":["https://openalex.org/I1288894424"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1288894424"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":1.7915,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.83597884,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"1","issue":"3","first_page":"111","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.3440000116825104,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.3440000116825104,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.30979999899864197,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.1826000064611435,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":1.0},{"id":"https://openalex.org/keywords/oxypurinol","display_name":"oxypurinol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/plasma-drug-determination","display_name":"plasma drug determination","score":0.6740000247955322},{"id":"https://openalex.org/keywords/purine-metabolism","display_name":"purine metabolism","score":0.7310000061988831},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.43700000643730164},{"id":"https://openalex.org/keywords/purine-analogs","display_name":"purine analogues","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.7831189632415771},{"id":"https://openalex.org/C100243477","wikidata":"https://www.wikidata.org/wiki/Q12002092","display_name":"Welfare","level":2,"score":0.542926013469696},{"id":"https://openalex.org/C2778805511","wikidata":"https://www.wikidata.org/wiki/Q1713","display_name":"Citation","level":2,"score":0.4774751663208008},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.4723461866378784},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44406867027282715},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32403564453125},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.32234036922454834},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.29603856801986694},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1800694763660431},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.17694729566574097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11009132862091064}],"mesh":[{"descriptor_ui":"D000493","descriptor_name":"Allopurinol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010117","descriptor_name":"Oxypurinol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/bdd.2510010304","doi":"https://doi.org/10.1002/bdd.2510010304","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.2510010304","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},{"id":"pmid:7448337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7448337","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & drug disposition","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.766700029373169}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1566733503","https://openalex.org/W2010738902","https://openalex.org/W2024243897","https://openalex.org/W2035759495","https://openalex.org/W2036966181","https://openalex.org/W2039126859","https://openalex.org/W2051982486","https://openalex.org/W2076163613","https://openalex.org/W2080721371","https://openalex.org/W4234370858"],"related_works":["https://openalex.org/W2419537489","https://openalex.org/W2568725226","https://openalex.org/W2419367146","https://openalex.org/W6987273141","https://openalex.org/W2412100258","https://openalex.org/W2439025263","https://openalex.org/W2010738902","https://openalex.org/W2507455540","https://openalex.org/W2430953420","https://openalex.org/W4300810333"],"abstract_inverted_index":null,"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}